[Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
Reiner
Z
Z
Salzer
B
B
Kes
P
P
D000328:Adult; D000368:Aged; D005260:Female; D011345:Fenofibrate / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011422:Propionates / Q000008:administration & dosage*
D011422:Propionates; D011345:Fenofibrate
Usporedba ucinaka fenofibrata primijenjenog u dozama od 3 X 100 mg i 1 X 250 mg na dan u bolesnika s hiperlipoproteinemijom tipa IIA, IIB i IV.